{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T09:02:36Z","timestamp":1792141356113,"version":"4.4.0"},"reference-count":139,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2019,2,4]],"date-time":"2019-02-04T00:00:00Z","timestamp":1549238400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100006285","name":"Magnus Bergvalls Stiftelse","doi-asserted-by":"publisher","award":["2017-02138"],"award-info":[{"award-number":["2017-02138"]}],"id":[{"id":"10.13039\/501100006285","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Endocrine"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1007\/s12020-018-01835-3","type":"journal-article","created":{"date-parts":[[2019,2,4]],"date-time":"2019-02-04T10:27:18Z","timestamp":1549276038000},"page":"407-421","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":74,"title":["Clinical perspectives in congenital adrenal hyperplasia due to 3\u03b2-hydroxysteroid dehydrogenase type 2 deficiency"],"prefix":"10.1007","volume":"63","author":[{"given":"Abdullah M.","family":"Al Alawi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Nordenstr\u00f6m","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5622-6987","authenticated-orcid":false,"given":"Henrik","family":"Falhammar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,2,4]]},"reference":[{"issue":"3","key":"1835_CR1","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1007\/s12020-011-9591-x","volume":"41","author":"H Falhammar","year":"2012","unstructured":"H. Falhammar, M. Thoren, Clinical outcomes in the management of congenital adrenal hyperplasia. Endocrine 41(3), 355\u2013373 (2012). \n                    https:\/\/doi.org\/10.1007\/s12020-011-9591-x","journal-title":"Endocrine"},{"issue":"10108","key":"1835_CR2","doi-asserted-by":"publisher","first-page":"2194","DOI":"10.1016\/S0140-6736(17)31431-9","volume":"390","author":"D El-Maouche","year":"2017","unstructured":"D. El-Maouche, W. Arlt, D.P. Merke, Congenital adrenal hyperplasia. Lancet 390(10108), 2194\u20132210 (2017). \n                    https:\/\/doi.org\/10.1016\/S0140-6736(17)31431-9","journal-title":"Lancet"},{"issue":"3","key":"1835_CR3","doi-asserted-by":"publisher","first-page":"R125","DOI":"10.1530\/EJE-18-0279","volume":"179","author":"WL Miller","year":"2018","unstructured":"W.L. Miller, Mechanisms in endocrinology: rare defects in adrenal steroidogenesis. Eur. J. Endocrinol. 179(3), R125\u2013R141 (2018). \n                    https:\/\/doi.org\/10.1530\/EJE-18-0279","journal-title":"Eur. J. Endocrinol."},{"issue":"11","key":"1835_CR4","doi-asserted-by":"publisher","first-page":"5110","DOI":"10.1210\/jc.2010-0917","volume":"95","author":"W Arlt","year":"2010","unstructured":"W. Arlt, D.S. Willis, S.H. Wild, N. Krone, E.J. Doherty, S. Hahner, T.S. Han, P.V. Carroll, G.S. Conway, D.A. Rees, R.H. Stimson, B.R. Walker, J.M. Connell, R.J. Ross, United Kingdom Congenital Adrenal Hyperplasia Adult Study, Executive: Health status of adults with congenital adrenal hyperplasia: a cohort study of 203 patients. J. Clin. Endocrinol. Metab. 95(11), 5110\u20135121 (2010). \n                    https:\/\/doi.org\/10.1210\/jc.2010-0917","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"1","key":"1835_CR5","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/S2213-8587(13)70007-X","volume":"1","author":"S Gidlof","year":"2013","unstructured":"S. Gidlof, H. Falhammar, A. Thilen, U. von Dobeln, M. Ritzen, A. Wedell, A. Nordenstrom, One hundred years of congenital adrenal hyperplasia in Sweden: a retrospective, population-based cohort study. Lancet Diabetes Endocrinol. 1(1), 35\u201342 (2013). \n                    https:\/\/doi.org\/10.1016\/S2213-8587(13)70007-X","journal-title":"Lancet Diabetes Endocrinol."},{"issue":"1","key":"1835_CR6","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/s12020-016-1189-x","volume":"55","author":"K Bulsari","year":"2017","unstructured":"K. Bulsari, H. Falhammar, Clinical perspectives in congenital adrenal hyperplasia due to 11beta-hydroxylase deficiency. Endocrine 55(1), 19\u201336 (2017). \n                    https:\/\/doi.org\/10.1007\/s12020-016-1189-x","journal-title":"Endocrine"},{"issue":"11","key":"1835_CR7","doi-asserted-by":"publisher","first-page":"4043","DOI":"10.1210\/jc.2018-01865","volume":"103","author":"PW Speiser","year":"2018","unstructured":"P.W. Speiser, W. Arlt, R.J. Auchus, L.S. Baskin, G.S. Conway, D.P. Merke, H.F.L. Meyer-Bahlburg, W.L. Miller, M.H. Murad, S.E. Oberfield, P.C. White, Congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency: an endocrine society clinical practice guideline. J. Clin. Endocrinol. Metab. 103(11), 4043\u20134088 (2018). \n                    https:\/\/doi.org\/10.1210\/jc.2018-01865","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"3","key":"1835_CR8","doi-asserted-by":"publisher","first-page":"284","DOI":"10.4103\/0256-4947.81544","volume":"31","author":"NA Al-Jurayyan","year":"2011","unstructured":"N.A. Al-Jurayyan, Ambiguous genitalia: two decades of experience. Ann. Saudi Med. 31(3), 284\u2013288 (2011). \n                    https:\/\/doi.org\/10.4103\/0256-4947.81544","journal-title":"Ann. Saudi Med."},{"issue":"8","key":"1835_CR9","doi-asserted-by":"publisher","first-page":"E1105","DOI":"10.1210\/jc.2015-2098","volume":"100","author":"AR Benkert","year":"2015","unstructured":"A.R. Benkert, M. Young, D. Robinson, C. Hendrickson, P.A. Lee, K.A. Strauss, Severe salt-losing 3beta-hydroxysteroid dehydrogenase deficiency: treatment and outcomes of HSD3B2 c.35G>A homozygotes. J. Clin. Endocrinol. Metab. 100(8), E1105\u2013E1115 (2015). \n                    https:\/\/doi.org\/10.1210\/jc.2015-2098","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"3","key":"1835_CR10","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1530\/EC-17-0306","volume":"7","author":"B Donadille","year":"2018","unstructured":"B. Donadille, M. Houang, I. Netchine, J.P. Siffroi, S. Christin-Maitre, Human 3beta-hydroxysteroid dehydrogenase deficiency associated with normal spermatic numeration despite a severe enzyme deficit. Endocr. Connect 7(3), 395\u2013402 (2018). \n                    https:\/\/doi.org\/10.1530\/EC-17-0306","journal-title":"Endocr. Connect"},{"issue":"4","key":"1835_CR11","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1038\/ng0792-239","volume":"1","author":"E Rheaume","year":"1992","unstructured":"E. Rheaume, J. Simard, Y. Morel, F. Mebarki, M. Zachmann, M.G. Forest, M.I. New, F. Labrie, Congenital adrenal hyperplasia due to point mutations in the type II 3 beta-hydroxysteroid dehydrogenase gene. Nat. Genet 1(4), 239\u2013245 (1992). \n                    https:\/\/doi.org\/10.1038\/ng0792-239","journal-title":"Nat. Genet"},{"key":"1835_CR12","doi-asserted-by":"publisher","first-page":"2086","DOI":"10.1172\/JCI104666","volume":"41","author":"AM Bongiovanni","year":"1962","unstructured":"A.M. Bongiovanni, The adrenogenital syndrome with deficiency of 3 beta-hydroxysteroid dehydrogenase. J. Clin. Invest. 41, 2086\u20132092 (1962). \n                    https:\/\/doi.org\/10.1172\/JCI104666","journal-title":"J. Clin. Invest."},{"issue":"6","key":"1835_CR13","doi-asserted-by":"publisher","first-page":"2611","DOI":"10.1210\/jcem.87.6.8615","volume":"87","author":"C Lutfallah","year":"2002","unstructured":"C. Lutfallah, W. Wang, J.I. Mason, Y.T. Chang, A. Haider, B. Rich, M. Castro-Magana, K.C. Copeland, R. David, S. Pang, Newly proposed hormonal criteria via genotypic proof for type II 3beta-hydroxysteroid dehydrogenase deficiency. J. Clin. Endocrinol. Metab. 87(6), 2611\u20132622 (2002). \n                    https:\/\/doi.org\/10.1210\/jcem.87.6.8615","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"1","key":"1835_CR14","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/S0039-128X(96)00178-X","volume":"62","author":"Y Morel","year":"1997","unstructured":"Y. Morel, F. Mebarki, E. Rheaume, R. Sanchez, M.G. Forest, J. Simard, Structure-function relationships of 3 beta-hydroxysteroid dehydrogenase: contribution made by the molecular genetics of 3 beta-hydroxysteroid dehydrogenase deficiency. Steroids 62(1), 176\u2013184 (1997)","journal-title":"Steroids"},{"issue":"5","key":"1835_CR15","doi-asserted-by":"publisher","first-page":"1968","DOI":"10.1210\/jcem.85.5.6581","volume":"85","author":"N Alos","year":"2000","unstructured":"N. Alos, A.M. Moisan, L. Ward, M. Desrochers, L. Legault, G. Leboeuf, G. Van Vliet, J. Simard, A novel A10E homozygous mutation in the HSD3B2 gene causing severe salt-wasting 3beta-hydroxysteroid dehydrogenase deficiency in 46,XX and 46,XY French-Canadians: evaluation of gonadal function after puberty. J. Clin. Endocrinol. Metab. 85(5), 1968\u20131974 (2000). \n                    https:\/\/doi.org\/10.1210\/jcem.85.5.6581","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"12","key":"1835_CR16","doi-asserted-by":"publisher","first-page":"4410","DOI":"10.1210\/jcem.84.12.6288","volume":"84","author":"AM Moisan","year":"1999","unstructured":"A.M. Moisan, M.L. Ricketts, V. Tardy, M. Desrochers, F. Mebarki, J.L. Chaussain, S. Cabrol, M.C. Raux-Demay, M.G. Forest, W.G. Sippell, M. Peter, Y. Morel, J. Simard, New insight into the molecular basis of 3beta-hydroxysteroid dehydrogenase deficiency: identification of eight mutations in the HSD3B2 gene eleven patients from seven new families and comparison of the functional properties of twenty-five mutant enzymes. J. Clin. Endocrinol. Metab. 84(12), 4410\u20134425 (1999). \n                    https:\/\/doi.org\/10.1210\/jcem.84.12.6288","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"2","key":"1835_CR17","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.ecl.2015.02.002","volume":"44","author":"AF Turcu","year":"2015","unstructured":"A.F. Turcu, R.J. Auchus, Adrenal steroidogenesis and congenital adrenal hyperplasia. Endocrinol. Metab. Clin. North Am. 44(2), 275\u2013296 (2015). \n                    https:\/\/doi.org\/10.1016\/j.ecl.2015.02.002","journal-title":"Endocrinol. Metab. Clin. North Am."},{"issue":"5","key":"1835_CR18","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1016\/j.jpag.2017.04.001","volume":"30","author":"SF Witchel","year":"2017","unstructured":"S.F. Witchel, Congenital adrenal hyperplasia. J. Pediatr. Adolesc. Gynecol. 30(5), 520\u2013534 (2017). \n                    https:\/\/doi.org\/10.1016\/j.jpag.2017.04.001","journal-title":"J. Pediatr. Adolesc. Gynecol."},{"issue":"6","key":"1835_CR19","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1210\/er.2003-0030","volume":"25","author":"AH Payne","year":"2004","unstructured":"A.H. Payne, D.B. Hales, Overview of steroidogenic enzymes in the pathway from cholesterol to active steroid hormones. Endocr. Rev. 25(6), 947\u2013970 (2004). \n                    https:\/\/doi.org\/10.1210\/er.2003-0030","journal-title":"Endocr. Rev."},{"issue":"5","key":"1835_CR20","doi-asserted-by":"publisher","first-page":"K1","DOI":"10.1530\/EJE-15-0599","volume":"173","author":"MA Burckhardt","year":"2015","unstructured":"M.A. Burckhardt, S.S. Udhane, N. Marti, I. Schnyder, C. Tapia, J.E. Nielsen, P.E. Mullis, E. Rajpert-De Meyts, C.E. Fluck, Human 3beta-hydroxysteroid dehydrogenase deficiency seems to affect fertility but may not harbor a tumor risk: lesson from an experiment of nature. Eur. J. Endocrinol. 173(5), K1\u2013K12 (2015). \n                    https:\/\/doi.org\/10.1530\/EJE-15-0599","journal-title":"Eur. J. Endocrinol."},{"key":"1835_CR21","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/j.jsbmb.2014.03.008","volume":"145","author":"L Starka","year":"2015","unstructured":"L. Starka, M. Duskova, M. Hill, Dehydroepiandrosterone: a neuroactive steroid. J. Steroid Biochem Mol. Biol. 145, 254\u2013260 (2015). \n                    https:\/\/doi.org\/10.1016\/j.jsbmb.2014.03.008","journal-title":"J. Steroid Biochem Mol. Biol."},{"issue":"3","key":"1835_CR22","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1111\/j.1432-1033.1993.tb17580.x","volume":"211","author":"S Sharp","year":"1993","unstructured":"S. Sharp, E.V. Barker, M.W. Coughtrie, P.R. Lowenstein, R. Hume, Immunochemical characterisation of a dehydroepiandrosterone sulfotransferase in rats and humans. Eur. J. Biochem 211(3), 539\u2013548 (1993)","journal-title":"Eur. J. Biochem"},{"issue":"Suppl","key":"1835_CR23","first-page":"S125","volume":"150","author":"C Longcope","year":"1996","unstructured":"C. Longcope, Dehydroepiandrosterone metabolism. J. Endocrinol. 150(Suppl), S125\u2013127 (1996)","journal-title":"J. Endocrinol."},{"issue":"5","key":"1835_CR24","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1210\/mend.7.5.8316254","volume":"7","author":"J Simard","year":"1993","unstructured":"J. Simard, E. Rheaume, R. Sanchez, N. Laflamme, Y. de Launoit, V. Luu-The, A.P. van Seters, R.D. Gordon, M. Bettendorf, U. Heinrich et al.. Molecular basis of congenital adrenal hyperplasia due to 3 beta-hydroxysteroid dehydrogenase deficiency. Mol. Endocrinol. 7(5), 716\u2013728 (1993). \n                    https:\/\/doi.org\/10.1210\/mend.7.5.8316254","journal-title":"Mol. Endocrinol."},{"issue":"1","key":"1835_CR25","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/S0889-8529(08)70020-3","volume":"30","author":"S Pang","year":"2001","unstructured":"S. Pang, Congenital adrenal hyperplasia owing to 3 beta-hydroxysteroid dehydrogenase deficiency. Endocrinol. Metab. Clin. North Am. 30(1), 81\u201399 (2001).","journal-title":"Endocrinol. Metab. Clin. North Am."},{"key":"1835_CR26","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1056\/NEJM196306062682308","volume":"268","author":"AM Bongiovanni","year":"1963","unstructured":"A.M. Bongiovanni, A.W. Root, The adrenogenital syndrome. N. Engl. J. Med 268, 1283\u20131289 (1963). \n                    https:\/\/doi.org\/10.1056\/NEJM196306062682308\n                    \n                  .","journal-title":"N. Engl. J. Med"},{"issue":"1","key":"1835_CR27","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1038\/nm.2061","volume":"16","author":"M Doi","year":"2010","unstructured":"M. Doi, Y. Takahashi, R. Komatsu, F. Yamazaki, H. Yamada, S. Haraguchi, N. Emoto, Y. Okuno, G. Tsujimoto, A. Kanematsu, O. Ogawa, T. Todo, K. Tsutsui, G.T. van der Horst, H. Okamura, Salt-sensitive hypertension in circadian clock-deficient Cry-null mice involves dysregulated adrenal Hsd3b6. Nat. Med. 16(1), 67\u201374 (2010). \n                    https:\/\/doi.org\/10.1038\/nm.2061","journal-title":"Nat. Med."},{"key":"1835_CR28","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.mce.2017.08.022","volume":"461","author":"MM Alswailem","year":"2018","unstructured":"M.M. Alswailem, O.S. Alzahrani, D.S. Alhomaidah, R. Alasmari, E. Qasem, A.K. Murugan, A. Alsagheir, I. Brema, B.B. Abbas, M. Almehthel, A. Almeqbali, A.S. Alzahrani, Mutational analysis of rare subtypes of congenital adrenal hyperplasia in a highly inbred population. Mol. Cell. Endocrinol. 461, 105\u2013111 (2018). \n                    https:\/\/doi.org\/10.1016\/j.mce.2017.08.022","journal-title":"Mol. Cell. Endocrinol."},{"issue":"1-6","key":"1835_CR29","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/0960-0760(95)00043-Y","volume":"53","author":"J Simard","year":"1995","unstructured":"J. Simard, E. Rheaume, F. Mebarki, R. Sanchez, M.I. New, Y. Morel, F. Labrie, Molecular basis of human 3 beta-hydroxysteroid dehydrogenase deficiency. J. Steroid Biochem Mol. Biol. 53(1-6), 127\u2013138 (1995)","journal-title":"J. Steroid Biochem Mol. Biol."},{"issue":"1","key":"1835_CR30","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1210\/jcem.81.1.8550766","volume":"81","author":"L Zhang","year":"1996","unstructured":"L. Zhang, H. Sakkal-Alkaddour, Y.T. Chang, X. Yang, S. Pang, A new compound heterozygous frameshift mutation in the type II 3 beta-hydroxysteroid dehydrogenase (3 beta-HSD) gene causes salt-wasting 3 beta-HSD deficiency congenital adrenal hyperplasia. J. Clin. Endocrinol. Metab. 81(1), 291\u2013295 (1996). \n                    https:\/\/doi.org\/10.1210\/jcem.81.1.8550766","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"4","key":"1835_CR31","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1159\/000102593","volume":"68","author":"A Nordenstrom","year":"2007","unstructured":"A. Nordenstrom, M.G. Forest, A. Wedell, A case of 3beta-hydroxysteroid dehydrogenase type II (HSD3B2) deficiency picked up by neonatal screening for 21-hydroxylase deficiency: difficulties and delay in etiologic diagnosis. Horm. Res. 68(4), 204\u2013208 (2007). \n                    https:\/\/doi.org\/10.1159\/000102593","journal-title":"Horm. Res."},{"issue":"2","key":"1835_CR32","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/S1043-2760(98)00015-0","volume":"9","author":"S Pang","year":"1998","unstructured":"S. Pang, The molecular and clinical spectrum of 3beta-hydroxysteroid dehydrogenase deficiency disorder. Trends Endocrinol. Metab. 9(2), 82\u201386 (1998)","journal-title":"Trends Endocrinol. Metab."},{"issue":"9","key":"1835_CR33","first-page":"1293","volume":"25","author":"BS Bin-Abbas","year":"2004","unstructured":"B.S. Bin-Abbas, N.A. Sakati, A.A. Al-Ashwal, Congenital adrenal hyperplasia due to 3 beta-hydroxysteroid dehydrogenase type II deficiency in 4 Saudi children. Long term follow up. Saudi Med J. 25(9), 1293\u20131295 (2004)","journal-title":"Saudi Med J."},{"issue":"5-6","key":"1835_CR34","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/0960-0760(95)00198-0","volume":"55","author":"J Simard","year":"1995","unstructured":"J. Simard, R. Sanchez, F. Durocher, E. Rheaume, C. Turgeon, Y. Labrie, V. Luu-The, F. Mebarki, Y. Morel, Y. de Launoit et al.. Structure-function relationships and molecular genetics of the 3 beta-hydroxysteroid dehydrogenase gene family. J. Steroid Biochem Mol. Biol. 55(5-6), 489\u2013505 (1995)","journal-title":"J. Steroid Biochem Mol. Biol."},{"issue":"3","key":"1835_CR35","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1016\/S0015-0282(00)00668-3","volume":"74","author":"S Marui","year":"2000","unstructured":"S. Marui, A.J. Russell, F.J. Paula, I. Dick-de-Paula, J.A. Marcondes, B.B. Mendonca, Genotyping of the type II 3beta-hydroxysteroid dehydrogenase gene (HSD3B2) in women with hirsutism and elevated ACTH-stimulated delta(5)-steroids. Fertil. Steril. 74(3), 553\u2013557 (2000)","journal-title":"Fertil. Steril."},{"issue":"11","key":"1835_CR36","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1007\/s13312-015-0758-z","volume":"52","author":"MC Konar","year":"2015","unstructured":"M.C. Konar, S. Goswami, B.G. Babu, A.K. Mallick, Hypoglycemia due to 3beta-hydroxysteroid dehydrogenase type II deficiency in a newborn. Indian Pediatr. 52(11), 981\u2013983 (2015)","journal-title":"Indian Pediatr."},{"issue":"4","key":"1835_CR37","doi-asserted-by":"publisher","first-page":"2076","DOI":"10.1210\/jc.2004-1374","volume":"90","author":"TH Johannsen","year":"2005","unstructured":"T.H. Johannsen, D. Mallet, H. Dige-Petersen, J. Muller, K.M. Main, Y. Morel, M.G. Forest, Delayed diagnosis of congenital adrenal hyperplasia with salt wasting due to type II 3beta-hydroxysteroid dehydrogenase deficiency. J. Clin. Endocrinol. Metab. 90(4), 2076\u20132080 (2005). \n                    https:\/\/doi.org\/10.1210\/jc.2004-1374","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"6","key":"1835_CR38","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1016\/0022-4731(87)90396-7","volume":"28","author":"BB Mendonca","year":"1987","unstructured":"B.B. Mendonca, W. Bloise, I.J. Arnhold, M.C. Batista, S.P. Toledo, M.C. Drummond, W. Nicolau, E. Mattar, Male pseudohermaphroditism due to nonsalt-losing 3 beta-hydroxysteroid dehydrogenase deficiency: gender role change and absence of gynecomastia at puberty. J. Steroid Biochem. 28(6), 669\u2013675 (1987)","journal-title":"J. Steroid Biochem."},{"issue":"2","key":"1835_CR39","first-page":"66","volume":"42","author":"BB Mendonca","year":"1987","unstructured":"B.B. Mendonca, M.C. Batista, I.J. Arnhold, W. Nicolau, G. Madureira, V.S. Lando, M.B. Kohek, D.G. Carvalho, W. Bloise, Male pseudohermaphroditism due to 5 alpha reductase deficiency associated with gynecomastia. Rev. Hosp. Clin. Fac. Med. 42(2), 66\u201368 (1987)","journal-title":"Rev. Hosp. Clin. Fac. Med."},{"issue":"2","key":"1835_CR40","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1007\/s12020-016-1204-2","volume":"55","author":"RL Rushworth","year":"2017","unstructured":"R.L. Rushworth, D.J. Torpy, H. Falhammar, Adrenal crises: perspectives and research directions. Endocrine 55(2), 336\u2013345 (2017). \n                    https:\/\/doi.org\/10.1007\/s12020-016-1204-2","journal-title":"Endocrine"},{"issue":"5","key":"1835_CR41","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1159\/000481660","volume":"89","author":"RL Rushworth","year":"2018","unstructured":"R.L. Rushworth, D.J. Torpy, C.A. Stratakis, H. Falhammar, Adrenal crises in children: perspectives and research directions. Horm. Res. Paediatr. 89(5), 341\u2013351 (2018). \n                    https:\/\/doi.org\/10.1159\/000481660","journal-title":"Horm. Res. Paediatr."},{"issue":"2","key":"1835_CR42","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1210\/jc.2015-1710","volume":"101","author":"SR Bornstein","year":"2016","unstructured":"S.R. Bornstein, B. Allolio, W. Arlt, A. Barthel, A. Don-Wauchope, G.D. Hammer, E.S. Husebye, D.P. Merke, M.H. Murad, C.A. Stratakis, D.J. Torpy, Diagnosis and treatment of primary adrenal insufficiency: an endocrine society clinical practice guideline. J. Clin. Endocrinol. Metab. 101(2), 364\u2013389 (2016). \n                    https:\/\/doi.org\/10.1210\/jc.2015-1710","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"5","key":"1835_CR43","doi-asserted-by":"publisher","first-page":"P1","DOI":"10.1530\/EJE-16-0953","volume":"176","author":"A Kulle","year":"2017","unstructured":"A. Kulle, N. Krone, P.M. Holterhus, G. Schuler, R.F. Greaves, A. Juul, Y.B. de Rijke, M.F. Hartmann, A. Saba, O. Hiort, S.A. Wudy, E.C. Action, Steroid hormone analysis in diagnosis and treatment of DSD: position paper of EU COST Action BM 1303 \u2018DSDnet'. Eur. J. Endocrinol. 176(5), P1\u2013P9 (2017). \n                    https:\/\/doi.org\/10.1530\/EJE-16-0953","journal-title":"Eur. J. Endocrinol."},{"issue":"2","key":"1835_CR44","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.ando.2014.03.002","volume":"75","author":"CE Fluck","year":"2014","unstructured":"C.E. Fluck, A.V. Pandey, Steroidogenesis of the testis\u2014new genes and pathways. Ann. Endocrinol. 75(2), 40\u201347 (2014). \n                    https:\/\/doi.org\/10.1016\/j.ando.2014.03.002","journal-title":"Ann. Endocrinol."},{"issue":"1","key":"1835_CR45","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1002\/ccr3.742","volume":"5","author":"M Gortakowski","year":"2017","unstructured":"M. Gortakowski, R. Conroy, L. Aguiar, H. Allen, Premature pubarche in a child with abnormal 3beta-hydroxysteroid dehydrogenase function and Klinefelter syndrome: the intriguing relationship between androgen deficiency and excess. Clin. Case Rep. 5(1), 57\u201360 (2017). \n                    https:\/\/doi.org\/10.1002\/ccr3.742","journal-title":"Clin. Case Rep."},{"issue":"3","key":"1835_CR46","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1210\/jc.2004-1552","volume":"90","author":"LM Mermejo","year":"2005","unstructured":"L.M. Mermejo, L.L. Elias, S. Marui, A.C. Moreira, B.B. Mendonca, M. de Castro, Refining hormonal diagnosis of type II 3beta-hydroxysteroid dehydrogenase deficiency in patients with premature pubarche and hirsutism based on HSD3B2 genotyping. J. Clin. Endocrinol. Metab. 90(3), 1287\u20131293 (2005). \n                    https:\/\/doi.org\/10.1210\/jc.2004-1552","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"3","key":"1835_CR47","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1046\/j.1365-2265.2003.01716.x","volume":"58","author":"S Pang","year":"2003","unstructured":"S. Pang, G. Carbunaru, A. Haider, K.C. Copeland, Y.T. Chang, C. Lutfallah, J.I. Mason, Carriers for type II 3beta-hydroxysteroid dehydrogenase (HSD3B2) deficiency can only be identified by HSD3B2 genotype study and not by hormone test. Clin. Endocrinol. 58(3), 323\u2013331 (2003)","journal-title":"Clin. Endocrinol."},{"issue":"2","key":"1835_CR48","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1093\/hmg\/3.2.327","volume":"3","author":"J Simard","year":"1994","unstructured":"J. Simard, E. Rheaume, J.F. Leblanc, S.C. Wallis, G.F. Joplin, S. Gilbey, J. Allanson, G. Mettler, M. Bettendorf, U. Heinrich et al.. Congenital adrenal hyperplasia caused by a novel homozygous frameshift mutation 273 delta AA in type II 3 beta-hydroxysteroid dehydrogenase gene (HSD3B2) in three male patients of Afghan\/Pakistani origin. Human Mol. Genet. 3(2), 327\u2013330 (1994)","journal-title":"Human Mol. Genet."},{"issue":"9","key":"1835_CR49","doi-asserted-by":"publisher","first-page":"2893","DOI":"10.1021\/bi00009a020","volume":"34","author":"E Rheaume","year":"1995","unstructured":"E. Rheaume, R. Sanchez, F. Mebarki, E. Gagnon, J.C. Carel, J.L. Chaussain, Y. Morel, F. Labrie, J. Simard, Identification and characterization of the G15D mutation found in a male patient with 3 beta-hydroxysteroid dehydrogenase (3 beta-HSD) deficiency: alteration of the putative NAD-binding domain of type II 3 beta-HSD. Biochemistry 34(9), 2893\u20132900 (1995)","journal-title":"Biochemistry"},{"issue":"1","key":"1835_CR50","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1677\/jme.0.0120119","volume":"12","author":"BB Mendonca","year":"1994","unstructured":"B.B. Mendonca, A.J. Russell, M. Vasconcelos-Leite, I.J. Arnhold, W. Bloise, B.L. Wajchenberg, W. Nicolau, R.G. Sutcliffe, A.M. Wallace, Mutation in 3 beta-hydroxysteroid dehydrogenase type II associated with pseudohermaphroditism in males and premature pubarche or cryptic expression in females. J. Mol. Endocrinol. 12(1), 119\u2013122 (1994)","journal-title":"J. Mol. Endocrinol."},{"issue":"4","key":"1835_CR51","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1210\/jcem.79.4.7962268","volume":"79","author":"E Rheaume","year":"1994","unstructured":"E. Rheaume, R. Sanchez, J. Simard, Y.T. Chang, J. Wang, S. Pang, F. Labrie, Molecular basis of congenital adrenal hyperplasia in two siblings with classical nonsalt-losing 3 beta-hydroxysteroid dehydrogenase deficiency. J. Clin. Endocrinol. Metab. 79(4), 1012\u20131018 (1994). \n                    https:\/\/doi.org\/10.1210\/jcem.79.4.7962268","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"2","key":"1835_CR52","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1677\/jme.0.0120225","volume":"12","author":"AJ Russell","year":"1994","unstructured":"A.J. Russell, A.M. Wallace, M.G. Forest, M.D. Donaldson, C.R. Edwards, R.G. Sutcliffe, Mutation in the human gene for 3 beta-hydroxysteroid dehydrogenase type II leading to male pseudohermaphroditism without salt loss. J. Mol. Endocrinol. 12(2), 225\u2013237 (1994)","journal-title":"J. Mol. Endocrinol."},{"issue":"9","key":"1835_CR53","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.1093\/hmg\/3.9.1639","volume":"3","author":"R Sanchez","year":"1994","unstructured":"R. Sanchez, F. Mebarki, E. Rheaume, N. Laflamme, M.G. Forest, F. Bey-Omard, M. David, Y. Morel, F. Labrie, J. Simard, Functional characterization of the novel L108W and P186L mutations detected in the type II 3 beta-hydroxysteroid dehydrogenase gene of a male pseudohermaphrodite with congenital adrenal hyperplasia. Human Mol. Genet. 3(9), 1639\u20131645 (1994)","journal-title":"Human Mol. Genet."},{"issue":"3","key":"1835_CR54","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1210\/jcem.78.3.8126127","volume":"78","author":"R Sanchez","year":"1994","unstructured":"R. Sanchez, E. Rheaume, N. Laflamme, R.L. Rosenfield, F. Labrie, J. Simard, Detection and functional characterization of the novel missense mutation Y254D in type II 3 beta-hydroxysteroid dehydrogenase (3 beta HSD) gene of a female patient with nonsalt-losing 3 beta HSD deficiency. J. Clin. Endocrinol. Metab. 78(3), 561\u2013567 (1994). \n                    https:\/\/doi.org\/10.1210\/jcem.78.3.8126127","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"7","key":"1835_CR55","doi-asserted-by":"publisher","first-page":"2127","DOI":"10.1210\/jcem.80.7.7608265","volume":"80","author":"F Mebarki","year":"1995","unstructured":"F. Mebarki, R. Sanchez, E. Rheaume, N. Laflamme, J. Simard, M.G. Forest, F. Bey-Omar, M. David, F. Labrie, Y. Morel, Nonsalt-losing male pseudohermaphroditism due to the novel homozygous N100S mutation in the type II 3 beta-hydroxysteroid dehydrogenase gene. J. Clin. Endocrinol. Metab. 80(7), 2127\u20132134 (1995). \n                    https:\/\/doi.org\/10.1210\/jcem.80.7.7608265","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"5","key":"1835_CR56","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1093\/hmg\/4.5.969","volume":"4","author":"T Tajima","year":"1995","unstructured":"T. Tajima, K. Fujieda, J. Nakae, N. Shinohara, M. Yoshimoto, T. Baba, E. Kinoshita, Y. Igarashi, T. Oomura, Molecular analysis of type II 3 beta-hydroxysteroid dehydrogenase gene in Japanese patients with classical 3 beta-hydroxysteroid dehydrogenase deficiency. Hum. Mol. Genet 4(5), 969\u2013971 (1995)","journal-title":"Hum. Mol. Genet"},{"issue":"3","key":"1835_CR57","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1006\/mgme.1998.2715","volume":"64","author":"S Nayak","year":"1998","unstructured":"S. Nayak, P.A. Lee, S.F. Witchel, Variants of the type II 3beta-hydroxysteroid dehydrogenase gene in children with premature pubic hair and hyperandrogenic adolescents. Mol. Genet Metab. 64(3), 184\u2013192 (1998). \n                    https:\/\/doi.org\/10.1006\/mgme.1998.2715","journal-title":"Mol. Genet Metab."},{"issue":"6","key":"1835_CR58","doi-asserted-by":"publisher","first-page":"2556","DOI":"10.1210\/jcem.87.6.8559","volume":"87","author":"S Pang","year":"2002","unstructured":"S. Pang, W. Wang, B. Rich, R. David, Y.T. Chang, G. Carbunaru, S.E. Myers, A.F. Howie, K.J. Smillie, J.I. Mason, A novel nonstop mutation in the stop codon and a novel missense mutation in the type II 3beta-hydroxysteroid dehydrogenase (3beta-HSD) gene causing, respectively, nonclassic and classic 3beta-HSD deficiency congenital adrenal hyperplasia. J. Clin. Endocrinol. Metab. 87(6), 2556\u20132563 (2002). \n                    https:\/\/doi.org\/10.1210\/jcem.87.6.8559","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"4","key":"1835_CR59","doi-asserted-by":"publisher","first-page":"1418","DOI":"10.1210\/jc.2007-1874","volume":"93","author":"M Welzel","year":"2008","unstructured":"M. Welzel, N. Wustemann, G. Simic-Schleicher, H.G. Dorr, E. Schulze, G. Shaikh, P. Clayton, J. Grotzinger, P.M. Holterhus, F.G. Riepe, Carboxyl-terminal mutations in 3beta-hydroxysteroid dehydrogenase type II cause severe salt-wasting congenital adrenal hyperplasia. J. Clin. Endocrinol. Metab. 93(4), 1418\u20131425 (2008). \n                    https:\/\/doi.org\/10.1210\/jc.2007-1874","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"2","key":"1835_CR60","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.gene.2012.04.080","volume":"503","author":"B Rabbani","year":"2012","unstructured":"B. Rabbani, N. Mahdieh, M.T. Haghi Ashtiani, A. Setoodeh, A. Rabbani, In silico structural, functional and pathogenicity evaluation of a novel mutation: an overview of HSD3B2 gene mutations. Gene 503(2), 215\u2013221 (2012). \n                    https:\/\/doi.org\/10.1016\/j.gene.2012.04.080","journal-title":"Gene"},{"issue":"12","key":"1835_CR61","first-page":"948","volume":"52","author":"Y Huang","year":"2014","unstructured":"Y. Huang, J. Zheng, T. Xie, Q. Xiao, S. Lu, X. Li, J. Cheng, L. Chen, L. Liu, [A novel homozygous mutation p.E25X in the HSD3B2 gene causing salt wasting 3beta-hydroxysteroid dehydrogenases deficiency in a Chinese pubertal girl: a delayed diagnosis until recurrent ovary cysts]. Zhonghua Er Ke Za Zhi 52(12), 948\u2013951 (2014)","journal-title":"Zhonghua Er Ke Za Zhi"},{"issue":"1","key":"1835_CR62","doi-asserted-by":"publisher","first-page":"E191","DOI":"10.1210\/jc.2014-2676","volume":"100","author":"MS Baquedano","year":"2015","unstructured":"M.S. Baquedano, M. Ciaccio, R. Marino, N. Perez Garrido, P. Ramirez, M. Maceiras, A. Turjanski, L.A. Defelipe, M.A. Rivarola, A. Belgorosky, A novel missense mutation in the HSD3B2 gene, underlying nonsalt-wasting congenital adrenal hyperplasia. new insight into the structure-function relationships of 3beta-hydroxysteroid dehidrogenase type II. J. Clin. Endocrinol. Metab. 100(1), E191\u2013E196 (2015). \n                    https:\/\/doi.org\/10.1210\/jc.2014-2676","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"1","key":"1835_CR63","doi-asserted-by":"publisher","first-page":"85","DOI":"10.4274\/jcrpe.3306","volume":"9","author":"A Guven","year":"2017","unstructured":"A. Guven, S. Polat, Testicular Adrenal rest tumor in two brothers with a novel mutation in the 3-beta-hydroxysteroid dehydrogenase-2 gene. J. Clin. Res Pediatr. Endocrinol. 9(1), 85\u201390 (2017). \n                    https:\/\/doi.org\/10.4274\/jcrpe.3306","journal-title":"J. Clin. Res Pediatr. Endocrinol."},{"issue":"3","key":"1835_CR64","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1515\/jpem-2016-0348","volume":"30","author":"SL Teasdale","year":"2017","unstructured":"S.L. Teasdale, A. Morton, Adrenarche unmasks compound heterozygous 3beta-hydroxysteroid dehydrogenase deficiency: c.244G>A (p.Ala82Thr) and the novel 931C>T (p.Gln311*) variant in a non-salt wasting, severely undervirilised 46XY. J. Pediatr. Endocrinol. Metab. 30(3), 355\u2013360 (2017). \n                    https:\/\/doi.org\/10.1515\/jpem-2016-0348","journal-title":"J. Pediatr. Endocrinol. Metab."},{"key":"1835_CR65","doi-asserted-by":"publisher","unstructured":"V. G. Ara\u00fajo, R. S. Oliveira, K. P. Gameleira, C. B. Cruz, A. Lofrano-Porto, 3\u03b2-hydroxysteroid dehydrogenase type II deficiency on newborn screening test. Arq. Bras. Endocrinol. Metab. 58(6), 650\u2013655 (2014). \n                    https:\/\/doi.org\/10.1590\/0004-2730000003098","DOI":"10.1590\/0004-2730000003098"},{"issue":"1","key":"1835_CR66","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1186\/s13052-016-0282-3","volume":"42","author":"C Bizzarri","year":"2016","unstructured":"C. Bizzarri, N. Olivini, S. Pedicelli, R. Marini, G. Giannone, P. Cambiaso, M. Cappa, Congenital primary adrenal insufficiency and selective aldosterone defects presenting as salt-wasting in infancy: a single center 10-year experience. Ital. J. Pediatr. 42(1), 73 (2016). \n                    https:\/\/doi.org\/10.1186\/s13052-016-0282-3","journal-title":"Ital. J. Pediatr."},{"issue":"1","key":"1835_CR67","doi-asserted-by":"publisher","first-page":"25","DOI":"10.18388\/abp.2017_2343","volume":"65","author":"R Podgorski","year":"2018","unstructured":"R. Podgorski, D. Aebisher, M. Stompor, D. Podgorska, A. Mazur, Congenital adrenal hyperplasia: clinical symptoms and diagnostic methods. Acta Biochim. Pol. 65(1), 25\u201333 (2018). \n                    https:\/\/doi.org\/10.18388\/abp.2017_2343","journal-title":"Acta Biochim. Pol."},{"issue":"2","key":"1835_CR68","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1007\/s12020-015-0731-6","volume":"50","author":"H Falhammar","year":"2015","unstructured":"H. Falhammar, A. Wedell, A. Nordenstrom, Biochemical and genetic diagnosis of 21-hydroxylase deficiency. Endocrine 50(2), 306\u2013314 (2015). \n                    https:\/\/doi.org\/10.1007\/s12020-015-0731-6","journal-title":"Endocrine"},{"issue":"3","key":"1835_CR69","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/0002-9378(91)90280-5","volume":"165","author":"F Gonzalez","year":"1991","unstructured":"F. Gonzalez, D.A. Hatala, L. Speroff, Adrenal and ovarian steroid hormone responses to gonadotropin-releasing hormone agonist treatment in polycystic ovary syndrome. Am. J. Obstet. Gynecol. 165(3), 535\u2013545 (1991)","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"1","key":"1835_CR70","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1007\/s12020-015-0656-0","volume":"50","author":"H Falhammar","year":"2015","unstructured":"H. Falhammar, A. Nordenstrom, Nonclassic congenital adrenal hyperplasia due to 21-hydroxylase deficiency: clinical presentation, diagnosis, treatment, and outcome. Endocrine 50(1), 32\u201350 (2015). \n                    https:\/\/doi.org\/10.1007\/s12020-015-0656-0","journal-title":"Endocrine"},{"issue":"11","key":"1835_CR71","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1038\/gim.2017.46","volume":"19","author":"F Hannah-Shmouni","year":"2017","unstructured":"F. Hannah-Shmouni, R. Morissette, N. Sinaii, M. Elman, T.R. Prezant, W. Chen, A. Pulver, D.P. Merke, Revisiting the prevalence of nonclassic congenital adrenal hyperplasia in US Ashkenazi Jews and Caucasians. Genet Med 19(11), 1276\u20131279 (2017). \n                    https:\/\/doi.org\/10.1038\/gim.2017.46","journal-title":"Genet Med"},{"issue":"2","key":"1835_CR72","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1210\/jcem-33-2-269","volume":"33","author":"PA Parks","year":"1971","unstructured":"P.A. Parks, G.A. Bermudez, C.S. Anast, A.M. Bongiovanni, M.I. New, Pubertal boy with the 3\u03b2-hydroxy steroid dehydrogenase defect. J. Clin. Endocrinol. Metab. 33(2), 269\u2013278 (1971). \n                    https:\/\/doi.org\/10.1210\/jcem-33-2-269","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"1","key":"1835_CR73","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1210\/jcem-39-1-206","volume":"39","author":"O Janne","year":"1974","unstructured":"O. Janne, J. Perheentupa, L. Viinikka, R. Vihko, Testicular endocrine function in a pubertal boy with 3beta-hydroxysteroid dehydrogenase deficiency. J. Clin. Endocrinol. Metab. 39(1), 206\u2013209 (1974). \n                    https:\/\/doi.org\/10.1210\/jcem-39-1-206","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"5","key":"1835_CR74","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1210\/jcem.77.5.8077318","volume":"77","author":"YT Chang","year":"1993","unstructured":"Y.T. Chang, H.E. Kulin, L. Garibaldi, M.J. Suriano, K. Bracki, S. Pang, Hypothalamic-pituitary-gonadal axis function in pubertal male and female siblings with glucocorticoid-treated nonsalt-wasting 3 beta-hydroxysteroid dehydrogenase deficiency congenital adrenal hyperplasia. J. Clin. Endocrinol. Metab. 77(5), 1251\u20131257 (1993). \n                    https:\/\/doi.org\/10.1210\/jcem.77.5.8077318","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"6","key":"1835_CR75","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1210\/js.2018-00082","volume":"2","author":"E Lolis","year":"2018","unstructured":"E. Lolis, C.C. Juhlin, A. Nordenstrom, H. Falhammar, Extensive bilateral adrenal rest testicular tumors in a patient with 3beta-hydroxysteroid dehydrogenase type 2 deficiency. J. Endocr. Soc. 2(6), 513\u2013517 (2018). \n                    https:\/\/doi.org\/10.1210\/js.2018-00082","journal-title":"J. Endocr. Soc."},{"issue":"6","key":"1835_CR76","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1159\/000179067","volume":"11","author":"M Zachmann","year":"1979","unstructured":"M. Zachmann, M.G. Forest, E. De Peretti, 3 beta-hydroxysteroid dehydrogenase deficiency follow\u2014study a girl pubertal bone age. Horm. Res. 11(6), 292\u2013302 (1979). \n                    https:\/\/doi.org\/10.1159\/000179067","journal-title":"Horm. Res."},{"issue":"2","key":"1835_CR77","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1159\/000185492","volume":"48","author":"M Yoshimoto","year":"1997","unstructured":"M. Yoshimoto, T. Kawaguchi, R. Mori, E. Kinoshita, T. Baba, T. Tajima, K. Fujieda, T. Suzuki, H. Sasano, Pubertal changes in testicular 3 beta-hydroxysteroid dehydrogenase activity in a male with classical 3 beta-hydroxysteroid dehydrogenase deficiency showing spontaneous secondary sexual maturation. Horm. Res. 48(2), 83\u201387 (1997). \n                    https:\/\/doi.org\/10.1159\/000185492","journal-title":"Horm. Res."},{"issue":"4","key":"1835_CR78","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1172\/JCI107977","volume":"55","author":"G Schneider","year":"1975","unstructured":"G. Schneider, M. Genel, A.M. Bongiovanni, A.S. Goldman, R.L. Rosenfield, Persistent testicular delta5-isomerase-3beta-hydroxysteroid dehydrogenase (delta5-3beta-HSD) deficiency in the delta5-3beta-HSD form of congenital adrenal hyperplasia. J. Clin. Invest. 55(4), 681\u2013690 (1975). \n                    https:\/\/doi.org\/10.1172\/JCI107977","journal-title":"J. Clin. Invest."},{"issue":"8","key":"1835_CR79","first-page":"687","volume":"79","author":"J Jaaskelainen","year":"2000","unstructured":"J. Jaaskelainen, M. Hippelainen, O. Kiekara, R. Voutilainen, Child rate, pregnancy outcome and ovarian function in females with classical 21-hydroxylase deficiency. Acta Obstet. Gynecol. Scand. 79(8), 687\u2013692 (2000)","journal-title":"Acta Obstet. Gynecol. Scand."},{"issue":"4","key":"1835_CR80","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.1210\/jc.2006-1757","volume":"92","author":"F Gastaud","year":"2007","unstructured":"F. Gastaud, C. Bouvattier, L. Duranteau, R. Brauner, E. Thibaud, F. Kutten, P. Bougneres, Impaired sexual and reproductive outcomes in women with classical forms of congenital adrenal hyperplasia. J. Clin. Endocrinol. Metab. 92(4), 1391\u20131396 (2007). \n                    https:\/\/doi.org\/10.1210\/jc.2006-1757","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"7","key":"1835_CR81","doi-asserted-by":"publisher","first-page":"1607","DOI":"10.1093\/humrep\/den118","volume":"23","author":"K Hagenfeldt","year":"2008","unstructured":"K. Hagenfeldt, P.O. Janson, G. Holmdahl, H. Falhammar, H. Filipsson, L. Frisen, M. Thoren, A. Nordenskjold, Fertility and pregnancy outcome in women with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Hum. Reprod. 23(7), 1607\u20131613 (2008). \n                    https:\/\/doi.org\/10.1093\/humrep\/den118\n                    \n                  .","journal-title":"Hum. Reprod."},{"issue":"3","key":"1835_CR82","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1530\/EJE-11-0828","volume":"166","author":"H Falhammar","year":"2012","unstructured":"H. Falhammar, H.F. Nystrom, U. Ekstrom, S. Granberg, A. Wedell, M. Thoren, Fertility, sexuality and testicular adrenal rest tumors in adult males with congenital adrenal hyperplasia. Eur. J. Endocrinol. 166(3), 441\u2013449 (2012). \n                    https:\/\/doi.org\/10.1530\/EJE-11-0828","journal-title":"Eur. J. Endocrinol."},{"issue":"2","key":"1835_CR83","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/j.fertnstert.2013.11.002","volume":"101","author":"DE Reichman","year":"2014","unstructured":"D.E. Reichman, P.C. White, M.I. New, Z. Rosenwaks, Fertility in patients with congenital adrenal hyperplasia. Fertil. Steril. 101(2), 301\u2013309 (2014). \n                    https:\/\/doi.org\/10.1016\/j.fertnstert.2013.11.002","journal-title":"Fertil. Steril."},{"issue":"4","key":"1835_CR84","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.1210\/jc.2013-3326","volume":"99","author":"A Strandqvist","year":"2014","unstructured":"A. Strandqvist, H. Falhammar, P. Lichtenstein, A.L. Hirschberg, A. Wedell, C. Norrby, A. Nordenskjold, L. Frisen, A. Nordenstrom, Suboptimal psychosocial outcomes in patients with congenital adrenal hyperplasia: epidemiological studies in a nonbiased national cohort in Sweden. J. Clin. Endocrinol. Metab. 99(4), 1425\u20131432 (2014). \n                    https:\/\/doi.org\/10.1210\/jc.2013-3326","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"6","key":"1835_CR85","doi-asserted-by":"publisher","first-page":"2303","DOI":"10.1210\/jc.2014-4124","volume":"100","author":"C Bouvattier","year":"2015","unstructured":"C. Bouvattier, L. Esterle, P. Renoult-Pierre, A.B. de la Perriere, F. Illouz, V. Kerlan, V. Pascal-Vigneron, D. Drui, S. Christin-Maitre, F. Galland, T. Brue, Y. Reznik, F. Schillo, D. Pinsard, X. Piguel, G. Chabrier, B. Decoudier, P. Emy, I. Tauveron, M.L. Raffin-Sanson, J. Bertherat, J.M. Kuhn, P. Caron, M. Cartigny, O. Chabre, D. Dewailly, Y. Morel, P. Touraine, V. Tardy-Guidollet, J. Young, Clinical outcome, hormonal status, gonadotrope axis, and testicular function in 219 adult men born with classic 21-hydroxylase deficiency. A French National Survey. J. Clin. Endocrinol. Metab. 100(6), 2303\u20132313 (2015). \n                    https:\/\/doi.org\/10.1210\/jc.2014-4124","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"11","key":"1835_CR86","doi-asserted-by":"publisher","first-page":"4191","DOI":"10.1210\/jc.2017-01139","volume":"102","author":"H Falhammar","year":"2017","unstructured":"H. Falhammar, L. Frisen, C. Norrby, C. Almqvist, A.L. Hirschberg, A. Nordenskjold, A. Nordenstrom, Reduced frequency of biological and increased frequency of adopted children in males with 21-hydroxylase deficiency: a Swedish Population-Based National Cohort Study. J. Clin. Endocrinol. Metab. 102(11), 4191\u20134199 (2017). \n                    https:\/\/doi.org\/10.1210\/jc.2017-01139","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"4","key":"1835_CR87","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1530\/EJE-08-0311","volume":"159","author":"HL Claahsen-van der Grinten","year":"2008","unstructured":"H.L. Claahsen-van der Grinten, K. Duthoi, B.J. Otten, F.C. d'Ancona, C.A. Hulsbergen-vd Kaa, A.R. Hermus, An adrenal rest tumour in the perirenal region in a patient with congenital adrenal hyperplasia due to congenital 3beta-hydroxysteroid dehydrogenase deficiency. Eur. J. Endocrinol. 159(4), 489\u2013491 (2008). \n                    https:\/\/doi.org\/10.1530\/EJE-08-0311","journal-title":"Eur. J. Endocrinol."},{"issue":"12","key":"1835_CR88","doi-asserted-by":"publisher","first-page":"5721","DOI":"10.1210\/jcem.86.12.8090","volume":"86","author":"NM Stikkelbroeck","year":"2001","unstructured":"N.M. Stikkelbroeck, B.J. Otten, A. Pasic, G.J. Jager, C.G. Sweep, K. Noordam, A.R. Hermus, High prevalence of testicular adrenal rest tumors, impaired spermatogenesis, and Leydig cell failure in adolescent and adult males with congenital adrenal hyperplasia. J. Clin. Endocrinol. Metab. 86(12), 5721\u20135728 (2001)","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"3","key":"1835_CR89","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1530\/EJE-17-0862","volume":"178","author":"M Engels","year":"2018","unstructured":"M. Engels, K. Gehrmann, H. Falhammar, E.A. Webb, A. Nordenstrom, F.C. Sweep, P.N. Span, A.E. van Herwaarden, J. Rohayem, A. Richter-Unruh, C. Bouvattier, B. Kohler, B.B. Kortmann, W. Arlt, N. Roeleveld, N. Reisch, N. Stikkelbroeck, H.L. Claahsen-van der Grinten, Lg dsd, Gonadal function in adult male patients with congenital adrenal hyperplasia. Eur. J. Endocrinol. 178(3), 285\u2013294 (2018). \n                    https:\/\/doi.org\/10.1530\/EJE-17-0862","journal-title":"Eur. J. Endocrinol."},{"issue":"2","key":"1835_CR90","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.beem.2008.09.007","volume":"23","author":"HL Claahsen-van der Grinten","year":"2009","unstructured":"H.L. Claahsen-van der Grinten, B.J. Otten, M.M. Stikkelbroeck, F.C. Sweep, A.R. Hermus, Testicular adrenal rest tumours in congenital adrenal hyperplasia. Best. Pract. Res. Clin. Endocrinol. Metab. 23(2), 209\u2013220 (2009). \n                    https:\/\/doi.org\/10.1016\/j.beem.2008.09.007\n                    \n                  .","journal-title":"Best. Pract. Res. Clin. Endocrinol. Metab."},{"issue":"5","key":"1835_CR91","doi-asserted-by":"publisher","first-page":"R231","DOI":"10.1530\/EJE-17-0154","volume":"177","author":"G Mazziotti","year":"2017","unstructured":"G. Mazziotti, A.M. Formenti, S. Frara, E. Roca, P. Mortini, A. Berruti, A. Giustina, MANAGEMENT OF ENDOCRINE DISEASE: Risk of overtreatment in patients with adrenal insufficiency: current and emerging aspects. Eur. J. Endocrinol. 177(5), R231\u2013R248 (2017). \n                    https:\/\/doi.org\/10.1530\/EJE-17-0154","journal-title":"Eur. J. Endocrinol."},{"issue":"2","key":"1835_CR92","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/s12020-017-1501-4","volume":"59","author":"H Falhammar","year":"2018","unstructured":"H. Falhammar, Skeletal fragility induced by overtreatment of adrenal insufficiency. Endocrine 59(2), 239\u2013241 (2018). \n                    https:\/\/doi.org\/10.1007\/s12020-017-1501-4","journal-title":"Endocrine"},{"issue":"12","key":"1835_CR93","doi-asserted-by":"publisher","first-page":"4643","DOI":"10.1210\/jc.2007-0744","volume":"92","author":"H Falhammar","year":"2007","unstructured":"H. Falhammar, H. Filipsson, G. Holmdahl, P.O. Janson, A. Nordenskjold, K. Hagenfeldt, M. Thoren, Fractures and bone mineral density in adult women with 21-hydroxylase deficiency. J. Clin. Endocrinol. Metab. 92(12), 4643\u20134649 (2007). \n                    https:\/\/doi.org\/10.1210\/jc.2007-0744\n                    \n                  .","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"12","key":"1835_CR94","doi-asserted-by":"publisher","first-page":"4429","DOI":"10.1210\/jc.2012-2102","volume":"97","author":"GP Finkielstain","year":"2012","unstructured":"G.P. Finkielstain, M.S. Kim, N. Sinaii, M. Nishitani, C. Van Ryzin, S.C. Hill, J.C. Reynolds, R.M. Hanna, D.P. Merke, Clinical characteristics of a cohort of 244 patients with congenital adrenal hyperplasia. J. Clin. Endocrinol. Metab. 97(12), 4429\u20134438 (2012). \n                    https:\/\/doi.org\/10.1210\/jc.2012-2102","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"1","key":"1835_CR95","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1210\/jc.2011-2036","volume":"97","author":"KR Koetz","year":"2012","unstructured":"K.R. Koetz, M. Ventz, S. Diederich, M. Quinkler, Bone mineral density is not significantly reduced in adult patients on low-dose glucocorticoid replacement therapy. J. Clin. Endocrinol. Metab. 97(1), 85\u201392 (2012). \n                    https:\/\/doi.org\/10.1210\/jc.2011-2036\n                    \n                  .","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"4","key":"1835_CR96","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1530\/EJE-12-0196","volume":"167","author":"I Nermoen","year":"2012","unstructured":"I. Nermoen, I. Bronstad, K.J. Fougner, J. Svartberg, M. Oksnes, E.S. Husebye, K. Lovas, Genetic, anthropometric and metabolic features of adult Norwegian patients with 21-hydroxylase deficiency. Eur. J. Endocrinol. \/ Eur. Fed. Endocr. Soc. 167(4), 507\u2013516 (2012). \n                    https:\/\/doi.org\/10.1530\/EJE-12-0196\n                    \n                  .","journal-title":"Eur. J. Endocrinol. \/ Eur. Fed. Endocr. Soc."},{"issue":"3","key":"1835_CR97","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1530\/EJE-12-0865","volume":"168","author":"H Falhammar","year":"2013","unstructured":"H. Falhammar, H. Filipsson Nystrom, A. Wedell, K. Brismar, M. Thoren, Bone mineral density, bone markers, and fractures in adult males with congenital adrenal hyperplasia. Eur. J. Endocrinol. 168(3), 331\u2013341 (2013). \n                    https:\/\/doi.org\/10.1530\/EJE-12-0865","journal-title":"Eur. J. Endocrinol."},{"issue":"2","key":"1835_CR98","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1530\/EJE-14-0978","volume":"173","author":"A Bachelot","year":"2015","unstructured":"A. Bachelot, J.L. Golmard, J. Dulon, N. Dahmoune, M. Leban, C. Bouvattier, S. Cabrol, J. Leger, M. Polak, P. Touraine, Determining clinical and biological indicators for health outcomes in adult patients with childhood onset of congenital adrenal hyperplasia. Eur. J. Endocrinol. 173(2), 175\u2013184 (2015). \n                    https:\/\/doi.org\/10.1530\/EJE-14-0978","journal-title":"Eur. J. Endocrinol."},{"issue":"3","key":"1835_CR99","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1111\/cen.12507","volume":"82","author":"D El-Maouche","year":"2015","unstructured":"D. El-Maouche, S. Collier, M. Prasad, J.C. Reynolds, D.P. Merke, Cortical bone mineral density in patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Clin. Endocrinol. 82(3), 330\u2013337 (2015). \n                    https:\/\/doi.org\/10.1111\/cen.12507","journal-title":"Clin. Endocrinol."},{"issue":"2","key":"1835_CR100","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1530\/EJE-16-0104","volume":"175","author":"F Ceccato","year":"2016","unstructured":"F. Ceccato, M. Barbot, N. Albiger, M. Zilio, P. De Toni, G. Luisetto, M. Zaninotto, N.A. Greggio, M. Boscaro, C. Scaroni, V. Camozzi, Long-term glucocorticoid effect on bone mineral density in patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Eur. J. Endocrinol. 175(2), 101\u2013106 (2016). \n                    https:\/\/doi.org\/10.1530\/EJE-16-0104","journal-title":"Eur. J. Endocrinol."},{"issue":"3","key":"1835_CR101","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1210\/jc.2002-021074","volume":"88","author":"NM Stikkelbroeck","year":"2003","unstructured":"N.M. Stikkelbroeck, W.J. Oyen, G.J. van der Wilt, A.R. Hermus, B.J. Otten, Normal bone mineral density and lean body mass, but increased fat mass, in young adult patients with congenital adrenal hyperplasia. J. Clin. Endocrinol. Metab. 88(3), 1036\u20131042 (2003)","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"3","key":"1835_CR102","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1159\/000075588","volume":"61","author":"P Christiansen","year":"2004","unstructured":"P. Christiansen, C. Molgaard, J. Muller, Normal bone mineral content in young adults with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Horm. Res. 61(3), 133\u2013136 (2004). \n                    https:\/\/doi.org\/10.1159\/000075588\n                    \n                  .","journal-title":"Horm. Res."},{"issue":"3","key":"1835_CR103","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1530\/EC-18-0031","volume":"7","author":"H Falhammar","year":"2018","unstructured":"H. Falhammar, H. Claahsen-van der Grinten, N. Reisch, J. Slowikowska-Hilczer, A. Nordenstrom, R. Roehle, C. Bouvattier, B.P.C. Kreukels, B. Kohler, Lg dsd, Health status in 1040 adults with disorders of sex development (DSD): a European multicenter study. Endocr. Connect. 7(3), 466\u2013478 (2018). \n                    https:\/\/doi.org\/10.1530\/EC-18-0031","journal-title":"Endocr. Connect."},{"issue":"6","key":"1835_CR104","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1046\/j.1365-2265.1996.8620871.x","volume":"45","author":"J Jaaskelainen","year":"1996","unstructured":"J. Jaaskelainen, R. Voutilainen, Bone mineral density in relation to glucocorticoid substitution therapy in adult patients with 21-hydroxylase deficiency. Clin. Endocrinol. 45(6), 707\u2013713 (1996)","journal-title":"Clin. Endocrinol."},{"issue":"6","key":"1835_CR105","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1530\/EC-18-0160","volume":"7","author":"KR Frey","year":"2018","unstructured":"K.R. Frey, T. Kienitz, J. Schulz, M. Ventz, K. Zopf, M. Quinkler, Prednisolone is associated with a worse bone mineral density in primary adrenal insufficiency. Endocr. Connect. 7(6), 811\u2013818 (2018). \n                    https:\/\/doi.org\/10.1530\/EC-18-0160","journal-title":"Endocr. Connect."},{"issue":"5","key":"1835_CR106","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1530\/eje.0.1430667","volume":"143","author":"K Hagenfeldt","year":"2000","unstructured":"K. Hagenfeldt, E. Martin Ritzen, H. Ringertz, J. Helleday, K. Carlstrom, Bone mass and body composition of adult women with congenital virilizing 21-hydroxylase deficiency after glucocorticoid treatment since infancy. Eur. J. Endocrinol. 143(5), 667\u2013671 (2000). 1430667 [pii]","journal-title":"Eur. J. Endocrinol."},{"issue":"6","key":"1835_CR107","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1111\/cen.13580","volume":"88","author":"A Halper","year":"2018","unstructured":"A. Halper, B. Sanchez, J.S. Hodges, A.S. Kelly, D. Dengel, B.M. Nathan, A. Petryk, K. Sarafoglou, Bone mineral density and body composition in children with congenital adrenal hyperplasia. Clin. Endocrinol. 88(6), 813\u2013819 (2018). \n                    https:\/\/doi.org\/10.1111\/cen.13580","journal-title":"Clin. Endocrinol."},{"issue":"2","key":"1835_CR108","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1530\/EJE-10-0877","volume":"164","author":"H Falhammar","year":"2011","unstructured":"H. Falhammar, H. Filipsson Nystrom, A. Wedell, M. Thoren, Cardiovascular risk, metabolic profile, and body composition in adult males with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Eur. J. Endocrinol. 164(2), 285\u2013293 (2011). \n                    https:\/\/doi.org\/10.1530\/EJE-10-0877\n                    \n                  .","journal-title":"Eur. J. Endocrinol."},{"issue":"1","key":"1835_CR109","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1210\/jc.2006-1350","volume":"92","author":"H Falhammar","year":"2007","unstructured":"H. Falhammar, H. Filipsson, G. Holmdahl, P.O. Janson, A. Nordenskjold, K. Hagenfeldt, M. Thoren, Metabolic profile and body composition in adult women with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. J. Clin. Endocrinol. Metab. 92(1), 110\u2013116 (2007). \n                    https:\/\/doi.org\/10.1210\/jc.2006-1350\n                    \n                  .","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"4","key":"1835_CR110","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1507\/endocrj.K08E-312","volume":"56","author":"H Falhammar","year":"2009","unstructured":"H. Falhammar, H. Filipsson, G. Holmdahl, P.O. Janson, A. Nordenskjold, K. Hagenfeldt, M. Thoren, Increased liver enzymes in adult women with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Endocr. J. 56(4), 601\u2013608 (2009).","journal-title":"Endocr. J."},{"issue":"5","key":"1835_CR111","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1097\/MAJ.0b013e31824369e4","volume":"344","author":"MF Mnif","year":"2012","unstructured":"M.F. Mnif, M. Kamoun, F. Mnif, N. Charfi, N. Kallel, B. Ben Naceur, N. Rekik, Z. Mnif, M.H. Sfar, M.T. Sfar, M. Hachicha, L.A. Keskes, M. Abid, Long-term outcome of patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Am. J. Med. Sci. 344(5), 363\u2013373 (2012). \n                    https:\/\/doi.org\/10.1097\/MAJ.0b013e31824369e4","journal-title":"Am. J. Med. Sci."},{"issue":"2","key":"1835_CR112","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1093\/ajh\/hpv087","volume":"29","author":"W Bonfig","year":"2016","unstructured":"W. Bonfig, F.W. Roehl, S. Riedl, H.G. Dorr, M. Bettendorf, J. Bramswig, E. Schonau, F. Riepe, B. Hauffa, R.W. Holl, K. Mohnike, A.C.S. Group, Blood pressure in a large cohort of children and adolescents with classic adrenal hyperplasia (CAH) due to 21-hydroxylase deficiency. Am. J. Hypertens. 29(2), 266\u2013272 (2016). \n                    https:\/\/doi.org\/10.1093\/ajh\/hpv087","journal-title":"Am. J. Hypertens."},{"issue":"9","key":"1835_CR113","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1515\/jpem-2017-0068","volume":"30","author":"CF Mooij","year":"2017","unstructured":"C.F. Mooij, A.E. van Herwaarden, F. Sweep, N. Roeleveld, C.L. de Korte, L. Kapusta, H.L. Claahsen-van der Grinten, Cardiovascular and metabolic risk in pediatric patients with congenital adrenal hyperplasia due to 21 hydroxylase deficiency. J. Pediatr. Endocrinol. Metab. 30(9), 957\u2013966 (2017). \n                    https:\/\/doi.org\/10.1515\/jpem-2017-0068","journal-title":"J. Pediatr. Endocrinol. Metab."},{"issue":"4","key":"1835_CR114","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1111\/cen.13275","volume":"86","author":"R Ozdemir","year":"2017","unstructured":"R. Ozdemir, H.A. Korkmaz, M. Kucuk, C. Karadeniz, T. Mese, B. Ozkan, Assessment of early atherosclerosis and left ventricular dysfunction in children with 21-hydroxylase deficiency. Clin. Endocrinol. 86(4), 473\u2013479 (2017). \n                    https:\/\/doi.org\/10.1111\/cen.13275","journal-title":"Clin. Endocrinol."},{"issue":"3","key":"1835_CR115","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1111\/cen.13529","volume":"88","author":"CF Mooij","year":"2018","unstructured":"C.F. Mooij, M.S. Pourier, G. Weijers, C.L. de Korte, Z. Fejzic, H.L. Claahsen-van der Grinten, L. Kapusta, Cardiac function in paediatric patients with congenital adrenal hyperplasia due to 21 hydroxylase deficiency. Clin. Endocrinol. 88(3), 364\u2013371 (2018). \n                    https:\/\/doi.org\/10.1111\/cen.13529","journal-title":"Clin. Endocrinol."},{"key":"1835_CR116","doi-asserted-by":"publisher","unstructured":"D. Rosenbaum, A. Gallo, G. Lethielleux, E. Bruckert, B.I. Levy, M. L. Tanguy, J. Dulon, N. Dahmoune, J.E. Salem, R. Bittar, M. Leban, X. Girerd, P. Touraine, A. Bachelot, CARDIOHCS study group, Early central blood pressure elevation in adult patients with 21-hydroxylase deficiency. J. Hypertens. (2018). \n                    https:\/\/doi.org\/10.1097\/HJH.0000000000001850","DOI":"10.1097\/HJH.0000000000001850"},{"issue":"11","key":"1835_CR117","doi-asserted-by":"publisher","first-page":"4097","DOI":"10.1210\/jc.2018-01862","volume":"103","author":"S Tamhane","year":"2018","unstructured":"S. Tamhane, R. Rodriguez-Gutierrez, A.M. Iqbal, L.J. Prokop, I. Bancos, P.W. Speiser, M.H. Murad, cardiovascular and metabolic outcomes in congenital adrenal hyperplasia: a systematic review and meta-analysis. J. Clin. Endocrinol. Metab. 103(11), 4097\u20134103 (2018). \n                    https:\/\/doi.org\/10.1210\/jc.2018-01862","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"9","key":"1835_CR118","doi-asserted-by":"publisher","first-page":"3520","DOI":"10.1210\/JC.2015-2093","volume":"100","author":"H Falhammar","year":"2015","unstructured":"H. Falhammar, L. Frisen, A.L. Hirschberg, C. Norrby, C. Almqvist, A. Nordenskjold, A. Nordenstrom, Increased cardiovascular and metabolic morbidity in patients with 21-hydroxylase deficiency: a Swedish Population-Based National Cohort Study. J. Clin. Endocrinol. Metab. 100(9), 3520\u20133528 (2015). \n                    https:\/\/doi.org\/10.1210\/JC.2015-2093","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"1","key":"1835_CR119","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s12020-018-1723-0","volume":"62","author":"E Daae","year":"2018","unstructured":"E. Daae, K.B. Feragen, I. Nermoen, H. Falhammar, Psychological adjustment, quality of life, and self-perceptions of reproductive health in males with congenital adrenal hyperplasia: a systematic review. Endocrine 62(1), 3\u201313 (2018). \n                    https:\/\/doi.org\/10.1007\/s12020-018-1723-0","journal-title":"Endocrine"},{"issue":"3","key":"1835_CR120","doi-asserted-by":"publisher","first-page":"E554","DOI":"10.1210\/jc.2013-3707","volume":"99","author":"H Falhammar","year":"2014","unstructured":"H. Falhammar, A. Butwicka, M. Landen, P. Lichtenstein, A. Nordenskjold, A. Nordenstrom, L. Frisen, Increased psychiatric morbidity in men with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. J. Clin. Endocrinol. Metab. 99(3), E554\u2013E560 (2014). \n                    https:\/\/doi.org\/10.1210\/jc.2013-3707","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1835_CR121","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.psyneuen.2015.06.017","volume":"60","author":"H Engberg","year":"2015","unstructured":"H. Engberg, A. Butwicka, A. Nordenstrom, A.L. Hirschberg, H. Falhammar, P. Lichtenstein, A. Nordenskjold, L. Frisen, M. Landen, Congenital adrenal hyperplasia and risk for psychiatric disorders in girls and women born between 1915 and 2010: a total population study. Psychoneuroendocrinology 60, 195\u2013205 (2015). \n                    https:\/\/doi.org\/10.1016\/j.psyneuen.2015.06.017","journal-title":"Psychoneuroendocrinology"},{"issue":"4","key":"1835_CR122","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1530\/EJE-17-0895","volume":"178","author":"S Jenkins-Jones","year":"2018","unstructured":"S. Jenkins-Jones, L. Parviainen, J. Porter, M. Withe, M.J. Whitaker, S.E. Holden, C.L. Morgan, C.J. Currie, R.J.M. Ross, Poor compliance and increased mortality, depression and healthcare costs in patients with congenital adrenal hyperplasia. Eur. J. Endocrinol. 178(4), 309\u2013320 (2018). \n                    https:\/\/doi.org\/10.1530\/EJE-17-0895","journal-title":"Eur. J. Endocrinol."},{"issue":"2","key":"1835_CR123","first-page":"22","volume":"26","author":"H Selye","year":"1950","unstructured":"H. Selye, H. Stone, Hormonally induced transformation of adrenal into myeloid tissue. Am. J. Pathol. 26(2), 22 (1950)","journal-title":"Am. J. Pathol."},{"issue":"3","key":"1835_CR124","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1210\/jcem.74.3.1311000","volume":"74","author":"S Jaresch","year":"1992","unstructured":"S. Jaresch, E. Kornely, H.K. Kley, R. Schlaghecke, Adrenal incidentaloma and patients with homozygous or heterozygous congenital adrenal hyperplasia. J. Clin. Endocrinol. Metab. 74(3), 685\u2013689 (1992). \n                    https:\/\/doi.org\/10.1210\/jcem.74.3.1311000","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"1","key":"1835_CR125","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1007\/s12020-013-0162-1","volume":"47","author":"H Falhammar","year":"2014","unstructured":"H. Falhammar, Non-functioning adrenal incidentalomas caused by 21-hydroxylase deficiency or carrier status? Endocrine 47(1), 308\u2013314 (2014). \n                    https:\/\/doi.org\/10.1007\/s12020-013-0162-1","journal-title":"Endocrine"},{"issue":"5","key":"1835_CR126","doi-asserted-by":"publisher","first-page":"2065","DOI":"10.1210\/jc.2009-1929","volume":"95","author":"N Reisch","year":"2010","unstructured":"N. Reisch, M. Scherr, L. Flade, M. Bidlingmaier, H.P. Schwarz, U. Muller-Lisse, M. Reincke, M. Quinkler, F. Beuschlein, Total adrenal volume but not testicular adrenal rest tumor volume is associated with hormonal control in patients with 21-hydroxylase deficiency. J. Clin. Endocrinol. Metab. 95(5), 2065\u20132072 (2010). \n                    https:\/\/doi.org\/10.1210\/jc.2009-1929","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"6","key":"1835_CR127","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1111\/j.1365-2265.2011.04151.x","volume":"75","author":"I Nermoen","year":"2011","unstructured":"I. Nermoen, J. Rorvik, S.H. Holmedal, D.L. Hykkerud, K.J. Fougner, J. Svartberg, E.S. Husebye, K. Lovas, High frequency of adrenal myelolipomas and testicular adrenal rest tumours in adult Norwegian patients with classical congenital adrenal hyperplasia because of 21-hydroxylase deficiency. Clin. Endocrinol. 75(6), 753\u2013759 (2011). \n                    https:\/\/doi.org\/10.1111\/j.1365-2265.2011.04151.x","journal-title":"Clin. Endocrinol."},{"issue":"2","key":"1835_CR128","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1007\/s12020-017-1400-8","volume":"58","author":"J Patrova","year":"2017","unstructured":"J. Patrova, M. Kjellman, H. Wahrenberg, H. Falhammar, Increased mortality in patients with adrenal incidentalomas and autonomous cortisol secretion: a 13-year retrospective study from one center. Endocrine 58(2), 267\u2013275 (2017). \n                    https:\/\/doi.org\/10.1007\/s12020-017-1400-8","journal-title":"Endocrine"},{"issue":"1","key":"1835_CR129","first-page":"55","volume":"83","author":"L Barzon","year":"1998","unstructured":"L. Barzon, C. Scaroni, N. Sonino, F. Fallo, M. Gregianin, C. Macri, M. Boscaro, Incidentally discovered adrenal tumors: endocrine and scintigraphic correlates. J. Clin. Endocrinol. Metab. 83(1), 55\u201362 (1998)","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"3","key":"1835_CR130","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1530\/eje.0.1470349","volume":"147","author":"A Patocs","year":"2002","unstructured":"A. Patocs, M. Toth, C. Barta, M. Sasvari-Szekely, I. Varga, N. Szucs, C. Jakab, E. Glaz, K. Racz, Hormonal evaluation and mutation screening for steroid 21-hydroxylase deficiency in patients with unilateral and bilateral adrenal incidentalomas. Eur. J. Endocrinol. 147(3), 349\u2013355 (2002).","journal-title":"Eur. J. Endocrinol."},{"issue":"5","key":"1835_CR131","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1007\/BF03347226","volume":"28","author":"H Falhammar","year":"2005","unstructured":"H. Falhammar, M. Thoren, An 88-year-old woman diagnosed with adrenal tumor and congenital adrenal hyperplasia: connection or coincidence? J. Endocrinol. Investig. 28(5), 449\u2013453 (2005).","journal-title":"J. Endocrinol. Investig."},{"issue":"8","key":"1835_CR132","doi-asserted-by":"publisher","first-page":"870","DOI":"10.4158\/EP15618.OR","volume":"21","author":"J Patrova","year":"2015","unstructured":"J. Patrova, I. Jarocka, H. Wahrenberg, H. Falhammar, Clinical outcomes in adrenal incidentaloma: experience from one center. Endocr. Pract. 21(8), 870\u2013877 (2015). \n                    https:\/\/doi.org\/10.4158\/EP15618.OR","journal-title":"Endocr. Pract."},{"issue":"9","key":"1835_CR133","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1111\/imj.13177","volume":"46","author":"H Falhammar","year":"2016","unstructured":"H. Falhammar, D.J. Torpy, A 42-year-old man presented with adrenal incidentaloma due to non-classic congenital adrenal hyperplasia with a novel CYP21A2 mutation. Intern. Med. J. 46(9), 1115\u20131116 (2016). \n                    https:\/\/doi.org\/10.1111\/imj.13177","journal-title":"Intern. Med. J."},{"issue":"6","key":"1835_CR134","doi-asserted-by":"publisher","first-page":"736","DOI":"10.4158\/EP151085.RA","volume":"22","author":"H Falhammar","year":"2016","unstructured":"H. Falhammar, D.J. Torpy, Congenital adrenal hyperplasia due to 21-hydroxylase deficiency presenting as adrenal incidentaloma: a systematic review and meta-analysis. Endocr. Pract. 22(6), 736\u2013752 (2016). \n                    https:\/\/doi.org\/10.4158\/EP151085.RA","journal-title":"Endocr. Pract."},{"issue":"12","key":"1835_CR135","doi-asserted-by":"publisher","first-page":"E2715","DOI":"10.1210\/jc.2014-2957","volume":"99","author":"H Falhammar","year":"2014","unstructured":"H. Falhammar, L. Frisen, C. Norrby, A.L. Hirschberg, C. Almqvist, A. Nordenskjold, A. Nordenstrom, Increased mortality in patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. J. Clin. Endocrinol. Metab. 99(12), E2715\u2013E2721 (2014). \n                    https:\/\/doi.org\/10.1210\/jc.2014-2957","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"2","key":"1835_CR136","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1210\/jc.2007-0556","volume":"93","author":"A Nordenskjold","year":"2008","unstructured":"A. Nordenskjold, G. Holmdahl, L. Frisen, H. Falhammar, H. Filipsson, M. Thoren, P.O. Janson, K. Hagenfeldt, Type of mutation and surgical procedure affect long-term quality of life for women with congenital adrenal hyperplasia. J. Clin. Endocrinol. Metab. 93(2), 380\u2013386 (2008). \n                    https:\/\/doi.org\/10.1210\/jc.2007-0556\n                    \n                  .","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"11","key":"1835_CR137","doi-asserted-by":"publisher","first-page":"4089","DOI":"10.1210\/jc.2018-01863","volume":"103","author":"J Almasri","year":"2018","unstructured":"J. Almasri, F. Zaiem, R. Rodriguez-Gutierrez, S.U. Tamhane, A.M. Iqbal, L.J. Prokop, P.W. Speiser, L.S. Baskin, I. Bancos, M.H. Murad, Genital reconstructive surgery in females with congenital adrenal hyperplasia: a systematic review and meta-analysis. J. Clin. Endocrinol. Metab. 103(11), 4089\u20134096 (2018). \n                    https:\/\/doi.org\/10.1210\/jc.2018-01863","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1835_CR138","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.eucr.2018.02.011","volume":"18","author":"AR Fernandez-Aristi","year":"2018","unstructured":"A.R. Fernandez-Aristi, A.A. Taco-Masias, L. Montesinos-Baca, Case report: Clitoromegaly as a consequence of Congenital Adrenal Hyperplasia. An accurate medical and surgical approach. Urol. Case Rep. 18, 57\u201359 (2018). \n                    https:\/\/doi.org\/10.1016\/j.eucr.2018.02.011","journal-title":"Urol. Case Rep."},{"key":"1835_CR139","doi-asserted-by":"publisher","unstructured":"D. MacKay, A. Nordenstrom, H. Falhammar, Bilateral adrenalectomy in congenital adrenal hyperplasia: a systematic review and meta-analysis. J. Clin. Endocrinol. Metab. (2018). \n                    https:\/\/doi.org\/10.1210\/jc.2018-00217","DOI":"10.1210\/jc.2018-00217"}],"container-title":["Endocrine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12020-018-01835-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-018-01835-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-018-01835-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,3]],"date-time":"2020-02-03T19:18:17Z","timestamp":1580757497000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12020-018-01835-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,4]]},"references-count":139,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,3]]}},"alternative-id":["1835"],"URL":"https:\/\/doi.org\/10.1007\/s12020-018-01835-3","relation":{},"ISSN":["1355-008X","1559-0100"],"issn-type":[{"value":"1355-008X","type":"print"},{"value":"1559-0100","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,2,4]]},"assertion":[{"value":"24 November 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 December 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 February 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}